Children with severe asthma have more than 30 times the risk of developing adult chronic obstructive lung disease (COPD) as adults compared to children without asthma, according to a prospective longitudinal cohort study from the Royal Children’s Hospital in Melbourne.
Long-term, regular use of vitamin E in women 45 years of age and older may help decrease the risk of chronic obstructive pulmonary disease (COPD) by about 10 percent in both smokers and non-smokers, according to a study conducted by researchers at Cornell University and Brigham and Women’s Hospital.
People who live in urban areas where particulate air pollution is high tend to have higher blood pressure than those who live in less polluted areas, according to researchers from the University of Dusiburg-Essen in Germany.
Obese patients with chronic obstructive pulmonary disease (COPD) stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
Surviving heart failure calls for lifestyle changes, taking medications and following doctor’s orders.
Researchers from Case Western Reserve University, Kent State University, Summa Health System and University Hospitals Case Medical Center will find out if subtle cognitive impairments cause the adherence problems in heart failure cases.
Annual heart disease and stroke rates in China will rise by up to 73 percent by 2030, given an aging population and other increased risk factors, without policies and prevention efforts aimed at controlling blood pressure and smoking, according to research from Columbia University Medical Center published in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Researchers at Johns Hopkins have discovered that a compound in dark chocolate may protect the brain after a stroke by increasing cellular signals already known to shield nerve cells from damage.
FAU researcher who was the first to demonstrate that aspirin prevents a first heart attack proposes that individuals who have a heart attack on aspirin do so, in part, because they aren't taking the drug or are taking NSAIDs.
Tuesday, May 4, is Stroke Alert day.
Sometimes, even a severe stroke can have a happy ending. Patients can significantly minimize the severity of strokes by receiving treatment within three hours.
Dallas-based Trajectory Health, LLC has announced a partnership with HeartMath® to deliver clinical stress management solutions to the corporate marketplace.
Studies presented at ASH 2010 test the effectiveness of electronic health records and automated performance measures to control blood pressure and cut the risk of death.
Data presented at ASH 2010 suggest early therapeutic approaches may be appropriate for patients with pre-diabetes, pre-hypertension, or both conditions
Data suggest need for ambulatory monitoring for children and adolescents of hypertensives who appear to have normal blood pressure in the doctor’s office
New research suggests a component in a layer of tissue surrounding grains of brown rice may work against angiotensin II. Angiotensin II is a protein and known culprit in the development of high blood pressure & atherosclerosis.
A class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) may provide a boost to cardiovascular health by affecting the way platelets, small cells in the blood involved in clotting, clump together.
Researchers have found there are racial differences in the activity of enzymes that make or breakdown a major regulator of blood pressure. The results correlate with the bias of African Americans being more at risk.
Researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered why statins — popular drugs that lower cholesterol and appear to protect against colorectal cancer development — work for some people, but not for all.
Consuming a higher amount of added sugars in processed or prepared foods is associated with lower levels of high-density lipoprotein cholesterol (HDL-C, the “good cholesterol”) and higher levels of triglycerides, which are important risk factors for cardiovascular disease, according to a study in the April 21 issue of JAMA.
Albert Einstein College of Medicine of Yeshiva University has been awarded $750,000 by the John D. and Catherine T. MacArthur Foundation to study the impact of housing on the cardiovascular health of Latinos in the Bronx.
A new review finds that many patients who take an anti-clotting drug or “blood-thinner” can benefit from monitoring the levels of the drug themselves instead of going to clinics for blood tests.
Patients who do not have health care insurance, or those with insurance but financial concerns about accessing health care, are more likely to delay seeking emergency care for a heart attack, according to a study in the April 14 issue of JAMA.
A study in this week's Journal of the American Medical Association shows patients, whether insured or not, delay care for a heart attack. The findings could impact the current debate about U.S. health care reform as affordability continues to be a challenge for patients.
Obstructive sleep apnea (OSA) is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.
In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no clear safety benefits. The review, to be published in the April 23 issue of the Journal of the American College of Cardiology, assessed data on dronedarone submitted during the drug's FDA approval process and determined that dronedarone is 50 percent less effective than amiodarone (Cordarone), a frequently used treatment for atrial fibrillation, a common type of heart rhythm disorder.
Buddy Conant was a ticking heart-attack bomb when he joined the Century Health Study of The University of Texas Health Science Center at Houston (UTHealth). Armed with a PET scan of his injured heart, he has changed his life.
The Foundation for Art & Healing releases the proceedings from its groundbreaking Arts and the Heart Roundtable (AHR), regarding the connection between creative engagement and cardiac health.
A new edition of Cardiac Intensive Care, the only textbook dedicated to cardiac intensive care medicine, chronicles the progress made in the diagnosis and treatment of patients with critical cardiac illness.
Physician-scientists at the Cedars-Sinai Heart Institute have found that a genetic variation is associated with lower risk of sudden cardiac arrest, a disorder that gives little warning and is fatal in about 95 percent of cases. Findings will be published tomorrow by the Public Library of Science (PloS One).
New research finds that there is an inverse association between the level of supine (lying face up) systolic blood pressure measured on admission to an intensive care unit for acute chest pain and risk of death at one year, with those patients having high systolic blood pressure having a better prognosis after a year, according to a study in the March 24/31 issue of JAMA.
Patients who suffer from plaque-related narrowing of a carotid artery but are not good candidates for open surgery may be eligible to participate in a clinical trial at Cedars-Sinai Medical Center of a minimally invasive procedure designed to open carotid arteries the way angioplasty and stenting clear arteries of the heart.
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center.
A study questions the effectiveness of routine aspirin therapy in preventing heart disease, while another suggests that LVADs may aid in weight loss for obese patients awaiting a heart transplant.
Chronic feelings of loneliness take a toll on blood pressure over time, causing a marked increase after four years. A new study shows, for the first time, a direct relation between loneliness and larger increases in blood pressure four years later—a link that is independent of age and other factors that could cause blood pressure to rise.
An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.
People whose “bad” cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.
New Saint Louis University research found that beta blockers are underused in heart failure patients who receive an implantable cardiac device, suggesting a reliance on technology rather than conventional drug therapy.
The first edition of James Toole’s Cerebrovascular Disorders, published in 1967, was the first modern stroke textbook. Now, more than 40 years later and through five editions, a new edition has been released for both specialists and residents.
Researchers from Mount Sinai School of Medicine have found that patients admitted to hospice care who have an implantable cardioverter defibrillator (ICD) are rarely having their ICDs deactivated and are receiving electrical shocks from these devices near the end of life.
New data reported at a scientific meeting from the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) finds the overall safety and efficacy of the two procedures essentially the same. But in those age 69 and younger, the stenting works better than the surgery, says the chair of biostatistics at UAB and other researchers, and the surgery seems to work better in those age 70 and higher.
The CREST trial that compared traditional surgery with less-invasive stenting to clear dangerously clogged carotid arteries in the neck is being called "seminal and robust."
A large nationwide study that includes neurologists from Mayo Clinic has found that blacks are substantially less likely than whites to know that they have atrial fibrillation or to use warfarin, the most common treatment for the condition. Atrial fibrillation, an abnormal heart rhythm, significantly increases risk of stroke. Warfarin is known to reduce that risk.
For dialysis patients, high scores on a new fatigue rating scale predict an increased risk of heart attack or other cardiovascular events, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
A study by Indiana U. prof Marieke Van Puymbroeck found that a modified version of cardiac rehab helped reduce risk factors for stroke after Transient Ischemic Attacks, or "mini strokes." No post-TIA rehab exists to help prevent future strokes.